Bal Pharma Financials
NSE: BALPHARMA | BSE: 524824
₹87.73
₹0.02
(0.02%)
As on 04-Sep-2026 15:51IST
Market cap
₹141 Cr
Revenue (TTM)
₹334 Cr
P/E Ratio
19.6
P/B Ratio
1.7
Div. Yield
1.4 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
334.41
|
311.66
|
303.08
|
339.22
|
304.22
|
281.21
|
|
|
|
|
|
|
Total Income
|
336.05
|
313.59
|
305.29
|
342.07
|
305.16
|
286.37
|
|
|
|
|
|
|
Total Expenditure
|
300.62
|
279.55
|
273.32
|
308.28
|
278.97
|
257.24
|
|
|
|
|
|
|
EBITDA
|
33.79
|
32.11
|
29.76
|
30.94
|
25.25
|
23.98
|
|
|
|
|
|
|
Depreciation
|
11.34
|
11.08
|
9.77
|
10.07
|
9.13
|
9.04
|
|
|
|
|
|
|
EBIT
|
22.45
|
21.03
|
19.99
|
20.86
|
16.12
|
14.94
|
|
|
|
|
|
|
Interest
|
17.23
|
17.02
|
17.05
|
14.67
|
12.31
|
10.91
|
|
|
|
|
|
|
Other Income
|
1.64
|
1.93
|
2.20
|
2.85
|
0.94
|
5.15
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
6.86
|
5.93
|
5.14
|
9.05
|
4.75
|
9.18
|
|
|
|
|
|
|
Provision for Tax
|
-0.39
|
-0.39
|
-2.10
|
1.60
|
2.13
|
3.48
|
|
|
|
|
|
|
Profit after Tax
|
7.25
|
6.32
|
7.24
|
7.45
|
2.62
|
5.70
|
|
|
|
|
|
|
Minority Interest
|
-0.04
|
-0.04
|
-0.02
|
-0.05
|
-0.05
|
-0.09
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
7.21
|
6.28
|
7.22
|
7.39
|
2.57
|
5.61
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
82.23
|
82.23
|
77.42
|
72.00
|
63.79
|
58.63
|
|
|
|
|
|
|
Minority Interest
|
-0.04
|
0.03
|
-0.01
|
-0.03
|
-0.09
|
-0.13
|
|
|
|
|
|
|
Non-Current Liabilities
|
44.06
|
43.26
|
38.38
|
44.81
|
37.97
|
36.40
|
|
|
|
|
|
|
Current Liabilities
|
249.23
|
249.23
|
219.50
|
203.06
|
209.33
|
165.65
|
|
|
|
|
|
|
Total Liabilities
|
375.54
|
375.54
|
335.69
|
319.84
|
311.01
|
260.53
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
102.23
|
112.50
|
100.41
|
85.68
|
82.85
|
75.96
|
|
|
|
|
|
|
Current Assets
|
262.23
|
262.23
|
234.87
|
234.16
|
228.16
|
184.57
|
|
|
|
|
|
|
Total Assets
|
375.54
|
375.54
|
335.69
|
319.84
|
311.01
|
260.53
|
|
|
|
|
|
|
Total Debt*
|
--
|
159.52
|
150.38
|
139.60
|
131.00
|
103.64
|
|
|
|
|
|
|
Net Current Assets
|
13.01
|
13.01
|
15.37
|
31.10
|
18.82
|
18.93
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
5.58
|
17.10
|
16.96
|
16.44
|
16.25
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
30.84
|
20.32
|
22.81
|
-1.54
|
26.80
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-20.70
|
-14.92
|
-18.89
|
-22.18
|
-9.48
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-9.59
|
-7.84
|
-1.21
|
24.09
|
-17.22
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
0.55
|
-2.44
|
2.71
|
0.37
|
0.09
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
4.53
|
3.95
|
4.53
|
4.68
|
1.64
|
3.79
|
|
|
|
|
|
|
Cash EPS (₹)
|
4.53
|
10.93
|
10.68
|
11.08
|
7.49
|
9.95
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
52.36
|
51.65
|
48.63
|
45.56
|
40.66
|
38.92
|
|
|
|
|
|
|
Dividend per Share (₹)
|
1.36
|
1.20
|
1.20
|
1.20
|
1.00
|
1.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
19.37
|
12.76
|
14.43
|
-0.98
|
18.08
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-4.16
|
-5.82
|
1.58
|
-19.38
|
5.35
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
9.78
|
10.10
|
11.67
|
9.56
|
12.33
|
|
|
|
|
|
|
ROE (%)
|
8.98
|
7.92
|
9.69
|
10.97
|
4.31
|
10.34
|
|
|
|
|
|
|
ROA (%)
|
2.04
|
1.78
|
2.21
|
2.36
|
0.92
|
2.28
|
|
|
|
|
|
|
EBIT Margin (%)
|
6.71
|
6.75
|
6.60
|
6.15
|
5.30
|
5.31
|
|
|
|
|
|
|
Net Margin (%)
|
2.16
|
2.02
|
2.37
|
2.18
|
0.86
|
1.99
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
5.58
|
5.61
|
5.16
|
3.86
|
5.24
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
13.51
|
2.83
|
-10.65
|
11.51
|
8.18
|
12.25
|
|
|
|
|
|
|
EBIT Growth (%)
|
16.36
|
5.21
|
-4.20
|
29.42
|
7.92
|
-1.21
|
|
|
|
|
|
|
Net Profit Growth (%)
|
0.67
|
-12.67
|
-2.81
|
184.26
|
-54.09
|
21.07
|
|
|
|
|
|
|
EPS Growth (%)
|
0.71
|
-12.91
|
-3.11
|
185.36
|
-56.70
|
18.33
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
6.22
|
7.52
|
12.88
|
10.57
|
9.58
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
19.56
|
15.24
|
18.35
|
19.51
|
40.83
|
28.49
|
|
|
|
|
|
|
Price / Book Value
|
1.69
|
1.16
|
1.71
|
2.00
|
1.65
|
2.77
|
|
|
|
|
|
|
Dividend Yield (%)
|
1.36
|
2.00
|
1.44
|
1.32
|
1.49
|
0.93
|
|
|
|
|
|
|
EV/EBITDA
|
8.28
|
7.29
|
8.60
|
8.01
|
8.72
|
8.86
|
|
|
|
|
|
|
Close Price (₹)
|
79.55
|
60.42
|
83.90
|
91.20
|
67.05
|
107.90
|
|
|
|
|
|
|
High Price (₹)
|
112.97
|
128.86
|
157.98
|
132.45
|
134.40
|
148.85
|
|
|
|
|
|
|
Low Price (₹)
|
59.69
|
59.69
|
76.30
|
63.35
|
63.35
|
53.00
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
140.98
|
95.74
|
132.39
|
144.20
|
105.02
|
159.86
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.39
|
1.94
|
1.94
|
1.94
|
2.05
|
1.80
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
1.37
|
1.39
|
1.33
|
1.45
|
1.21
|
|
|
|
|
|
|
Current Ratio
|
1.05
|
1.05
|
1.07
|
1.15
|
1.09
|
1.11
|
|
|
|
|
|
|
Quick Ratio
|
0.59
|
0.59
|
0.60
|
0.72
|
0.62
|
0.67
|
|
|
|
|
|
|
Interest Coverage
|
1.40
|
1.35
|
1.30
|
1.62
|
1.39
|
1.84
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
28.00
|
30.04
|
30.50
|
29.37
|
30.89
|
26.78
|
|
|
|
|
|
|
Asset Turnover
|
0.94
|
0.88
|
0.93
|
1.08
|
1.06
|
1.12
|
|
|
|
|
|
|
Receivable days
|
--
|
108.96
|
115.65
|
104.16
|
101.56
|
92.48
|
|
|
|
|
|
|
Inventory Days
|
--
|
128.46
|
114.91
|
99.97
|
103.42
|
87.47
|
|
|
|
|
|
|
Payable days
|
--
|
219.58
|
202.96
|
162.36
|
165.90
|
132.11
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
17.84
|
27.60
|
41.77
|
39.08
|
47.85
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
